- Home
- AMBC vs PCRX Comparison
AMBC vs PCRX Comparison
Compare AMBC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- PCRX
- Stock Information
- Founded
- AMBC 1991
- PCRX 2006
- Country
- AMBC United States
- PCRX United States
- Employees
- AMBC N/A
- PCRX N/A
- Industry
- AMBC Property-Casualty Insurers
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- PCRX Health Care
- Exchange
- AMBC Nasdaq
- PCRX Nasdaq
- Market Cap
- AMBC 543.0M
- PCRX 1.2B
- IPO Year
- AMBC 1991
- PCRX 2011
- Fundamental
- Price
- AMBC $11.56
- PCRX $26.09
- Analyst Decision
- AMBC Strong Buy
- PCRX Buy
- Analyst Count
- AMBC 2
- PCRX 10
- Target Price
- AMBC $17.00
- PCRX $29.30
- AVG Volume (30 Days)
- AMBC 431.2K
- PCRX 892.8K
- Earning Date
- AMBC 02-25-2025
- PCRX 02-27-2025
- Dividend Yield
- AMBC N/A
- PCRX N/A
- EPS Growth
- AMBC N/A
- PCRX N/A
- EPS
- AMBC N/A
- PCRX N/A
- Revenue
- AMBC $398,000,000.00
- PCRX $694,957,000.00
- Revenue This Year
- AMBC N/A
- PCRX $5.14
- Revenue Next Year
- AMBC N/A
- PCRX $2.44
- P/E Ratio
- AMBC N/A
- PCRX N/A
- Revenue Growth
- AMBC 22.46
- PCRX 4.40
- 52 Week Low
- AMBC $10.12
- PCRX $11.16
- 52 Week High
- AMBC $18.45
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- AMBC 45.24
- PCRX 77.75
- Support Level
- AMBC $11.35
- PCRX $25.06
- Resistance Level
- AMBC $11.72
- PCRX $27.10
- Average True Range (ATR)
- AMBC 0.31
- PCRX 1.45
- MACD
- AMBC 0.05
- PCRX 0.28
- Stochastic Oscillator
- AMBC 59.15
- PCRX 86.23
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.